CHARLES M. BAUM - 19 Dec 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
President,Founder,Head of R&D, Director
Signature
/s/ Reena R. Desai, Attorney-in-Fact
Issuer symbol
MRTX
Transactions as of
19 Dec 2022
Transactions value $
-$367,469
Form type
4
Filing time
21 Dec 2022, 20:21:33 UTC
Previous filing
28 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +53.6K +41.92% $0.00 182K 19 Dec 2022 Direct F1
transaction MRTX Common Stock Sale -$367K -9.09K -5.01% $40.42 172K 21 Dec 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Performance Stock Units ("PSUs"). 1/3 of the PSUs have vested on December 19, 2022 (one week after the "Achievement Date" of December 12, 2022). 1/3 of the remaining shares will vest on the one year anniversary of the Achievement Date and the remaining 1/3 will vest on the two year anniversary of the Achievement Date, subject to Mr. Baum's continuous service.
F2 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1.